Cargando…

Outcomes of single- or dual-chamber implantable cardioverter defibrillator systems in Japanese patients

BACKGROUND: There are no criteria for selecting single- or dual-chamber implantable cardioverter defibrillators (ICDs) in patients without a pacing indication. Recent reports showed no benefit of the dual-chamber system despite its preference in the United States. As data on ICD selection and respec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ueda, Akiko, Oginosawa, Yasushi, Soejima, Kyoko, Abe, Haruhiko, Kohno, Ritsuko, Ohe, Hisaharu, Momose, Yuichi, Nagaoka, Mika, Matsushita, Noriko, Hoshida, Kyoko, Miwa, Yosuke, Miyakoshi, Mutsumi, Togashi, Ikuko, Maeda, Akiko, Sato, Toshiaki, Yoshino, Hideaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823579/ https://www.ncbi.nlm.nih.gov/pubmed/27092188 http://dx.doi.org/10.1016/j.joa.2015.09.007

Ejemplares similares

Elongated ascending aorta predicts a short distance between his-bundle potential recording site and coronary sinus ostium()
por: Momose, Yuichi, et al.
Publicado: (2017)

Reducing radiation exposure during atrial fibrillation ablation using lectures to promote awareness
por: Miwa, Yosuke, et al.
Publicado: (2019)

Fluoroscopic predictors of acceptable capture threshold during the implantation of the micra transcatheter pacing system
por: Togashi, Ikuko, et al.
Publicado: (2022)

Assessing the perforation site of cardiac tamponade during radiofrequency catheter ablation using gas analysis of pericardial effusion
por: Katsume, Yumi, et al.
Publicado: (2020)

Subclinical cardiac perforation caused by a Micra™ leadless pacemaker
por: Togashi, Ikuko, et al.
Publicado: (2018)

RR interval variability in the evaluation of ventricular tachycardia and effects of implantable cardioverter defibrillator therapy
por: Tsukahara, Keita, et al.
Publicado: (2021)

Epicardial access and ventricular tachycardia ablation in a postmyocarditis patient using a nonfluoroscopic catheter visualization system
por: Ueda, Akiko, et al.
Publicado: (2017)

A case of balloon angioplasty guided by integrated backscatter intravascular ultrasound for the treatment of pulmonary vein stenosis caused by radiofrequency atrial fibrillation
por: Tsukahara, Keita, et al.
Publicado: (2019)

Diverse QRS morphology reflecting variations in lead placement for left bundle branch area pacing
por: Sato, Toshiaki, et al.
Publicado: (2023)

Accuracy of wristwatch-type photoplethysmography in detecting atrial fibrillation in daily life( )
por: Nonoguchi, Noriko Matsushita, et al.
Publicado: (2022)

Incidence of out-of-hospital cardiac arrests and survival rates after 1 month among the Japanese working population: a cohort study
por: Yamagishi, Yasunobu, et al.
Publicado: (2021)

Primary cardiac B-cell lymphoma involving sinus node, presenting as sick sinus syndrome
por: Mohri, Takato, et al.
Publicado: (2020)

Different characteristics of heart failure due to pump failure and bradyarrhythmia
por: Iwataki, Mai, et al.
Publicado: (2014)

“Carryover phenomenon” in subcutaneous implantable cardioverter‐defibrillator: Residual energy caused early shock to subsequent ventricular tachycardia
por: Yamagishi, Yasunobu, et al.
Publicado: (2022)

Trends in the use of implantable cardioverter‐defibrillator and cardiac resynchronization therapy device in advancing age: Analysis of the Japan cardiac device treatment registry database
por: Yokoshiki, Hisashi, et al.
Publicado: (2020)

Inappropriate implantable cardioverter defibrillator shocks—incidence, effect, and implications for driver licensing
por: Watanabe, Eiichi, et al.
Publicado: (2017)

Driving restrictions in patients with implantable cardioverter defibrillators and pacemakers
por: Watanabe, Eiichi, et al.
Publicado: (2017)

Clinical, electrocardiographic, and echocardiographic parameters associated with the development of pacing and implantable cardioverter-defibrillator indication in patients with transthyretin amyloid cardiomyopathy
por: Kawahara, Yusei, et al.
Publicado: (2023)

Implantable cardioverter-defibrillators /
Publicado: (1994)

Risk factors for the first and second inappropriate implantable cardioverter-defibrillator therapy
por: Nishii, Nobuhiro, et al.
Publicado: (2021)

Resolution of a warfarin and dabigatran-resistant left atrial appendage thrombus with apixaban
por: Miwa, Yosuke, et al.
Publicado: (2016)

The Automatic External Cardioverter-Defibrillator
por: Martínez-Rubio, Antoni, et al.
Publicado: (2004)

Deactivation of implantable cardioverter-defibrillators
por: Wan, Darryl, et al.
Publicado: (2021)

The subcutaneous implantable cardioverter-defibrillator should be considered for all patients with an implantable cardioverter-defibrillator indication
por: Tan, Jian Liang, et al.
Publicado: (2022)

Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator
por: Jazayeri, Mohammad-Ali, et al.
Publicado: (2017)

Defibrillation Testing of the Implantable Cardioverter Defibrillator: When, How, and by Whom?
por: Pires, Luis A
Publicado: (2007)

Predictors of Elevated Defibrillation Threshold with the Subcutaneous Implantable Cardioverter-defibrillator
por: Do, Khuyen, et al.
Publicado: (2017)

Remote Monitoring of Implantable Cardioverter Defibrillator
por: Reynolds, Dwight W, et al.
Publicado: (2006)

The Subcutaneous Implantable Cardioverter-Defibrillator: Not For All
por: Nair, Krishnakumar, et al.
Publicado: (2014)

Programming implantable cardioverter/defibrillators and outcomes
por: Horlbeck, Fritz W., et al.
Publicado: (2015)

Implantable cardioverter–defibrillator in hypertrophic cardiomyopathy
por: Sanchez, Diego Jimenez, et al.
Publicado: (2018)

Implantation of Implantable Cardioverter Defibrillators in Kazakhstan
por: Begisbayev, Temirkhan, et al.
Publicado: (2022)

Characteristics of Cardiac Memory in Patients with Implanted Cardioverter-defibrillators: The Cardiac Memory with Implantable Cardioverter-defibrillator (CAMI) Study
por: Haq, Kazi T., et al.
Publicado: (2021)

Relation of multicenter automatic defibrillator implantation trial implantable cardioverter-defibrillator score with long-term cardiovascular events in patients with implantable cardioverter-defibrillator
por: Uslu, Abdulkadir, et al.
Publicado: (2018)

Unusual fracture in a Durata lead with shock coil fragmentation and cable externalization
por: Sato, Toshiaki, et al.
Publicado: (2017)

Influence of primary and secondary prevention indications on anxiety about the implantable cardioverter-defibrillator
por: Rahmawati, Anita, et al.
Publicado: (2016)

Higher defibrillation threshold in methamphetamine cardiomyopathy patients with implantable cardioverter-defibrillator
por: Malhotra, Rakesh, et al.
Publicado: (2017)

Impairment of Quality of Life in Patients with Implanted Subcutaneous Cardioverter Defibrillator (S-ICD) Compared to Implanted Transvenous Cardioverter Defibrillator Therapy
por: Thienel, Manuela, et al.
Publicado: (2022)

Quality of Life in Patients with Implantable Cardioverter Defibrillators
por: Francis, Johnson, et al.
Publicado: (2006)

Perioperative Management of Patients with Implantable Cardioverter Defibrillators
por: Donnelly, Patrick, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_27dficfblsm25ps2qrvkha6gha